| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $98.0M | -66.8% |
| Cost of Revenue | $10.6M | +204.6% |
| R&D Expense | $186.7M | +4.5% |
| SG&A Expense | $81.0M | +6.1% |
| Operating Income | -$179.4M | -796.9% |
| Income Tax | $0 | — |
| Net Income | -$230.7M | -703.0% |
| EPS (Basic) | -$0.78 | -609.1% |
| EPS (Diluted) | -$0.78 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $178.7M | -38.8% |
| Short-term Investments | $14.7M | -2.1% |
| Accounts Receivable | $2.7M | +80.6% |
| Current Assets | $213.1M | -35.8% |
| Total Assets | $413.6M | -11.2% |
| Current Liabilities | $189.0M | +20.4% |
| Long-term Debt | $12.6M | -1.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$175.4M | -1828.7% |
| Capital Expenditures | $53.1M | +56.9% |
| Investing Cash Flow | -$33.6M | +22.1% |
| Financing Cash Flow | $95.8M | -57.5% |
| Free Cash Flow | -$228.4M | -865.1% |
| -609.1% |
| Stockholders' Equity |
| -$61.3M |
| -277.9% |